Interventional Cardiology Devices Size, Share, Growth Analysis, By Product (Coronary Stents, Structural Heart Devices), By End User (Hospitals & ASCS, Catheterization Labs & Others), By Region - Industry Forecast 2025-2032

Interventional Cardiology Devices Market size was valued at USD 13.85 Billion in 2023 and is poised to grow from USD 14.86 Billion in 2024 to USD 26.12 Billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).

Interventional cardiologists are trained cardiovascular disease specialists. They are primarily concerned with the use of catheters, which are thin, flexible tubes used to carry out procedures. Angioplasty, stenting, and other procedures are carried out by directing equipment through the arteries of the body. For many people, these minimally invasive interventional procedures are an acceptable option to open surgery. These devices are primarily used to treat heart problems. It employs a single type of catheter that is inserted into the body and is used to treat cardiovascular diseases. This occurs as a result of hypertension, diabetes, and cardiovascular disease. In addition, these devices are used to treat peripheral vascular problems that affect the circulatory system and can give rise to plaque build-up in limb arteries. Catheters, balloons, stents, and filters are examples of interventional cardiology devices available on the market. The advancement of more advanced and innovative cardiovascular devices, and also the ease with which regulatory licences can be obtained are driving the market growth. However, various government regulations and stringent approval criteria may also limit growth of the business.

US Interventional Cardiology Devices Market is poised to grow at a sustainable CAGR for the next forecast year.